External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASN 2026
Roche and Genentech at

ASN 2026

October 21 - October 25
Denver, USA
asn-online.org
We will be contributing to topics related to
Nephrology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
02:00 PM
Duration 120mins Denver, USA
INShore Phase III Study of Obinutuzumab vs MMF in Childhood-Onset Idiopathic Nephrotic Syndrome: Post Hoc Analysis Assessing the Impact of Prior Rituximab Use
Larry A. Greenbaum, Julien Hogan, Kenneth Lieberman, Kandai Nozu, Małgorzata Mizerska-Wasiak, Clotilde Druck Garcia, Andrea Angeletti, Jie Ding, Xiaoyan Han, Sijing Li, Franz Schaefer, Patricia Lehane
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:30 PM
Duration 15mins Denver, USA
Sefaxersen, a Novel mRNA-targeted Therapy for IgA Nephropathy: Interim Analysis of the Phase 3 IMAgINATION Trial
Jonathan Barratt, Jürgen Floege, Irene Noronha, Dana V. Rizk, Hong Zhang, Xiaonong Chen, Dominique Chauveau, Dong Ki Kim, Pedro Augusto Macedo de Souza, Ji (Emmy) Cheng, Vishal Duggal, Nelson Guerreiro, Jeannette Lo, Nadine E. Schmit, Yixuan Zou, Sean Barbour
Nephrology | IgA nephropathy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:00 PM
Duration 120mins Denver, USA
Obinutuzumab Facilitates Tubular Repair in Lupus Nephritis Independently of Histologic or Clinical Response: Post Hoc Analyses of Urine EGF in the Phase III REGENCY Trial
Brad H. Rovin, Holly J. Clarke, Juan M. Mejia-Vilet, Ben Lanza, Peiqing Yu, Theodore A. Omachi, William F. Pendergraft III, Harini Raghu
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:30 PM
Duration 10mins Denver, USA
Efficacy and Safety of Obinutuzumab in Adolescents with Active Lupus Nephritis: Primary Results From POSTERITY, a Phase II Global Trial
Marina Vivarelli, Deborah M. Levy, Gabriel Vega Cornejo, Maria Teresa Terreri, Aleksandra Zurowska, Adolfina Elizabeth Zuta Santillán, Katharine Moore, Joan Calzada-Hernández, Julien Hogan, Sandra Enciso-Peláez, Agustín Remesal Camba, Louise Oni, Peiqing Yu, Felix Erblang, Olga Mitrofanova, William Pendergraft, Patricia Lehane
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.